NMAD (Nomad Power Solutions) Short Interest


NMAD Nomad Power Solutions Inc NMAD
32 GF Score
Price $6.46
! 1 Warning Sign
View Full Analysis

What is Nomad Power Solutions Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NMAD vs AGEN, COYA, GNLX: Short Interest Comparison

For the Electrical Equipment & Parts subindustry, Nomad Power Solutions's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nomad Power Solutions Short Interest vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Nomad Power Solutions's Short Interest distribution charts can be found below:

* The bar in red indicates where Nomad Power Solutions's Short Interest falls into.


NMAD
32GF Score
Nomad Power Solutions Inc NMAD
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nomad Power Solutions Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.
32GF Score

Get the complete analysis for NMAD

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.46
Price